SK Bioscience Co Ltd
KRX:302440

Watchlist Manager
SK Bioscience Co Ltd Logo
SK Bioscience Co Ltd
KRX:302440
Watchlist
Price: 48 700 KRW 1.46%
Market Cap: 3.8T KRW

Wall Street
Price Targets

Price Targets Summary
SK Bioscience Co Ltd

Wall Street analysts forecast SK Bioscience Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SK Bioscience Co Ltd is 38 505 KRW with a low forecast of 25 250 KRW and a high forecast of 52 500 KRW.

Lowest
Price Target
25 250 KRW
48% Downside
Average
Price Target
38 505 KRW
21% Downside
Highest
Price Target
52 500 KRW
8% Upside
SK Bioscience Co Ltd Competitors:
Price Targets
PHM
Pharma Mar SA
21% Upside
SYNACT
SynAct Pharma AB
10% Upside
PEB
Pacific Edge Ltd
31% Downside
TLX
Telix Pharmaceuticals Ltd
135% Upside
ADMA
ADMA Biologics Inc
43% Upside
UTHR
United Therapeutics Corp
13% Upside
ASMB
Assembly Biosciences Inc
52% Upside
OCGN
Ocugen Inc
388% Upside

Revenue
Forecast

Revenue Estimate
SK Bioscience Co Ltd

For the last 5 years the compound annual growth rate for SK Bioscience Co Ltd's revenue is 8%. The projected CAGR for the next 3 years is 42%.

8%
Past Growth
42%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
SK Bioscience Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss

Net Income
Forecast

Net Income Estimate
SK Bioscience Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-12%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SK Bioscience Co Ltd's stock price target?
Price Target
38 505 KRW

According to Wall Street analysts, the average 1-year price target for SK Bioscience Co Ltd is 38 505 KRW with a low forecast of 25 250 KRW and a high forecast of 52 500 KRW.

What is SK Bioscience Co Ltd's Revenue forecast?
Projected CAGR
42%

For the last 5 years the compound annual growth rate for SK Bioscience Co Ltd's revenue is 8%. The projected CAGR for the next 3 years is 42%.

Back to Top